---
created: 2025-04-13
updated: 2025-04-13T10:52
id: BrrL2c>1x?
specialty: pharmaco
specialty_id: 67
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/b&b::18-pulm::02-obstructive-&-restrictive-diseases::04-treatment-of-copd-&-asthma
  - "source/ak-step1-v11:": 
  - theme/firstaid::05-pharmacology::02-autonomic-drugs::14-b-blockers::b-agonists::b2-agonists::long-acting
  - "source/ak-step1-v11:": 
  - theme/firstaid::16-respiratory::05-pharm::07-asthma-drugs
  - "source/ak-step1-v11:": 
  - theme/firstaid::16-respiratory::05-pharm::07-asthma-drugs::long-acting-b2-agonists
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::04-general-physiology::14-smooth-muscle
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::08-respiratory::06-asthma-treatment
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::04-smooth-muscle::02-allergy-&-pulmonary::02-asthma-therapy
  - source/ak-step1-v11::^other::^highyield::2-relativelyhighyield
  - source/ak-step1-v11::^systems::respiratory::pharmacology"
type: flashcard
---

# Question
Long-acting Î²2 agonists are used for **prophylaxis** in moderate or severe persistent asthma

---

# Answer
